Peter R. Dolan

DEFINITION of 'Peter R. Dolan'

A former CEO of Bristol-Myers. Dolan joined the company in 1988 and held various senior management positions, becoming president in 2000 and chairman in 2001, a position he held through 2005. Dolan was dismissed in September 2006 because of a patent dispute over the blood-thinning blockbuster drug Plavix, a major source of the company's revenues. The dispute led to major sales losses when a generic equivalent went on the market. Although he was fired, Dolan received a severance package worth $1.2 million and pension benefits worth about $9.5 million.

BREAKING DOWN 'Peter R. Dolan'

Born in 1956 in Massachusetts, Dolan earned his MBA from Dartmouth's Tuck School of Business in 1980. Privately-held Gemin X Pharmaceuticals appointed Dolan to its board in 2008. He has also served as chairman of the board of Pharmaceutical Research and Manufacturers of America (PhRMA).

RELATED TERMS
  1. Blockbuster Drug

    An extremely popular drug that generates annual sales of at least ...
  2. Patent Cliff

    A colloquialism to denote the potential sharp decline in revenues ...
  3. E. Linn Draper Jr.

    A former chairman, CEO and president of Ohio-based public utility ...
  4. Medical Patent

    A legal protection against market competition that a government ...
  5. Patent Reexamination

    A process conducted by the U.S. Patent and Trademark Office (USPTO) ...
  6. Jamie Dimon

    The chairman, CEO and former president of JPMorgan Chase & ...
Related Articles
  1. Insights

    The Top 3 Exxon Mobil Shareholders (XOM)

    Learn about the three largest individual shareholders of Exxon Mobil Corporation (NYSE: XOM) stock, and the largest institutional and mutual fund holders.
  2. Insights

    Bristol-Myers' Earnings Forecasts a Healthy Dose of Growth

    You'd be hard-pressed to find a hotter health care stock with Bristol Myers' drug pipeline combined with its consistent execution.
  3. Markets

    Pharma Patent Trolls: Cheap Drugs At A Steep Price

    Though patent trolls can help patients achieve cheaper medication in the short-term, everyone pays for it in the long term.
  4. ETFs & Mutual Funds

    PJP: PowerShares Dynamic Pharmaceuticals ETF

    Learn about the PowerShares Dynamic Pharmaceuticals exchange-traded fund, which specializes on investing in pharmaceutical companies.
  5. Investing

    The Risks And Rewards Of Pharma Stocks

    While pharmaceutical stocks have certain risks, big pharma companies have stable cash flows and pricing power, offering opportunities for profit.
  6. ETFs & Mutual Funds

    Market Vectors Launches First Generic Drugs ETF (GNRX)

    Generic drugs have been a growing market in recent years. Now there is an ETF targeted at this market.
  7. Investing

    Evaluating Pharmaceutical Companies

    Learn how to find a healthy pharmaceutical investment in a market full of weak drugs.
  8. Markets

    Bristol-Myers Squibb Buys Into Hot Pharma Segment

    Bristol-Myers Squibb (NYSE: BMY) is readying itself for a fresh acquisition. The pharmaceutical giant announced last month that it has reached an agreement to acquire privately held biotechnology ...
  9. Markets

    Big Pharma: Will Price Pressure Happen No Matter What?

    Watch out for a possible decline in pharmaceutical stock prices, thanks to a renewed debate about the role of government policy and macroeconomic headwinds.
  10. Markets

    Why These Could Be 2015's 10-Best Pharma Stocks (ABBV, ALXN)

    The pharmaceutical stocks covered here have significant potential going forward. Here's why.
RELATED FAQS
  1. What are the major barriers to entry for new companies in the drugs sector?

    Find out why barriers to entry for U.S. drug companies are so high and how the Food and Drug Administration, or FDA, inhibits ... Read Answer >>
  2. What are the differences between brand name drugs and generic drugs?

    Discover the process by which brand name drugs lose their patent, allowing generics to be manufactured, as well as the differences ... Read Answer >>
  3. What countries comprise the majority of the global drugs sector?

    Find out which countries are the largest producers of pharmaceutical products in the world and why the United States dominates ... Read Answer >>
  4. How does the profit margin compare for a generic drug versus a brand name drug?

    Learn how the profit margins compare for generic drugs and brand-name drugs. Brand-name drugs cost three to four times more ... Read Answer >>
  5. How does government regulation impact the drugs sector?

    Learn about how drugs are regulated by the U.S. government as well as the role of the Food and Drug Administration during ... Read Answer >>
  6. How does the drug sector benefit from the growth of emerging markets?

    Understand how the pharmaceutical industry benefits from the growth of emerging markets. Benefits are linked to growing economies ... Read Answer >>
Hot Definitions
  1. Sell-Off

    The rapid selling of securities, such as stocks, bonds and commodities. The increase in supply leads to a decline in the ...
  2. Brazil, Russia, India And China - BRIC

    An acronym for the economies of Brazil, Russia, India and China combined. It has been speculated that by 2050 these four ...
  3. Brexit

    The Brexit, an abbreviation of "British exit" that mirrors the term Grexit, refers to the possibility of Britain's withdrawal ...
  4. Underweight

    1. A situation where a portfolio does not hold a sufficient amount of a particular security when compared to the security's ...
  5. Russell 3000 Index

    A market capitalization weighted equity index maintained by the Russell Investment Group that seeks to be a benchmark of ...
  6. Enterprise Value (EV)

    A measure of a company's value, often used as an alternative to straightforward market capitalization. Enterprise value is ...
Trading Center